OOIR: Observatory of International Research

Papers

(The TQCC of Current Opinion in Allergy and Clinical Immunology is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)

Article	Citations
The pathogenetic role of Th17 immune response in atopic dermatitis	53
What molecular allergy teaches us about genetics and epidemiology of allergies	31
The use of environmental exposure chambers in studies related to ocular surface effects	27
Economic burden of drug-induced anaphylaxis: what can we do better?	23
Drug allergy awareness and perspectives with the implementation of the International Classification of Diseases-11	22
Consequences of severe asthma exacerbations	21
Is immunotherapy safe for treatment of severe asthma	20
Liver disease in primary antibody deficiencies	19
Anaphylaxis due to antiallergic and antiasthmatic biologics	18
Dietary strategies for the prevention of asthma in children	18
Cow's milk allergy	17
E-cigarettes and asthma in adolescents	17
The collaborative medical practice of the ocular surface: a major role of the allergist/immunologist	17
Pulmonary function testing for the diagnosis of asthma in preschool children	17
Update on occupational allergy, including asthma, to soluble platinum salts	16
Chronic spontaneous urticaria: new evidences on the role of autoimmunity	16
Atopic manifestations of inborn errors of immunity	15
Innate and adaptive immunity in allergic airway disease	15
Bronchiectasis and obstructive lung diseases in primary antibody deficiencies and beyond: update on management and pathomechanisms	14
Mast cell conditions and drug allergy: when to suspect and how to manage	14
Editorial introductions	12
Perioperative anaphylaxis: when the allergological work-up goes negative	12
Real-world evidence of allergen immunotherapy	12
Epidemiology of the relationship between allergic bronchopulmonary aspergillosis and asthma	12
Transition of care in inborn errors of immunity	12

Neuroimmune signalling pathways in chronic rhinosinusitis with nasal polyps	12
Ocular involvement in allergic drug reactions	12
Editorial introductions	12
New approaches in childhood asthma treatment	12
Nanoparticles in allergen immunotherapy	11
Paucity of gastrointestinal plasma cells in common variable immunodeficiency	11
Drug allergy desensitization is not a unique recipe	11
Biological therapies, asthma and coronavirus disease 2019	11
LNIT-Local nasal immunotherapy in allergic rhinitis: revisited evidence and perspectives	10
A review of food allergy-related costs with consideration to clinical and demographic factors	10
Editorial introductions	10
An immunologist's perspective on anti-COVID-19 vaccines	10
Updates in diagnosis and management of paediatric mastocytosis	10
Is allergen immunotherapy a model of personalized treatment in pediatric respiratory allergy?	10
Editorial introductions	10
Editorial introductions	10
Health disparities in allergic diseases	9
Occupational causes of chronic obstructive pulmonary disease: an update	9
Clinical remission in severe asthma: lights and shadows on an ambitious goal	9
Chronic rhinosinusitis with nasal polyps: eosinophils versus B lymphocytes in disease pathogenesis	9
Editorial: Advances in drug hypersensitivity reactions	9
Basophil activation test in food allergy: is it ready for real-time?	9
Evaluating the glucagon-like peptide-1 receptor in managing asthma	8
Management and treatment of perioperative hypersensitivity	8
Atopic dermatitis endotypes: knowledge for personalized medicine	8
Food-labeling issues for severe food-allergic consumers	8
Monogenic forms of common variable immunodeficiency and implications on target therapeutic approaches	8
Updates in school-based asthma management	8
Greater mechanistic understanding of the cutaneous pathogenesis of Stevens–Johnson syndrome/toxic epidermal necrolysis can shed light on novel therapeutic strategies: a comprehensive review	8
Current strategies for phenotyping and managing asthma in preschool children	7
What's new in pediatric asthma and rhinitis phenotypes and endotypes?	7
Editorial introductions	7
Role of the ocular surface microbiome in allergic eye diseases	7
Do bacterial vaccines/adjuvants prevent wheezing episodes in children?	7
Strengthening the case for intralymphatic immunotherapy	7
Update on hereditary C1q deficiency: pathophysiology, clinical presentation, genotype and management	7
Food allergy: new therapeutic options open deeper questions	7
Precision allergy molecular diagnosis applications in food allergy	7
The complexity in DNA methylation analysis of allergic diseases	7
Biomarkers in the diagnosis of mast cell activation	7
Atopic dermatitis and ocular allergy: common mechanisms and uncommon questions	6
The role of macrolides in chronic rhinosinusitis and nasal polyps	6
Access from healthcare professionals to evidence-based pharmacotherapy in allergy management	6
Giant cell arteritis and innovative treatments	6
Neurotrophic keratitis: inflammatory pathogenesis and novel therapies	6
Mechanisms underlying host defense and disease pathology in response to severe acute respiratory syndrome (SARS)-CoV2 infection: insights from inborn errors of immunity	6
Immunobiologicals and ocular surface disease	6
Occupational respiratory allergy to reactive dyes	6
Adverse effects of anti-cancer biologics on the ocular surface	6
Predictive models and applicability of artificial intelligence-based approaches in drug allergy	6

Interstitial lung diseases in inborn errors of immunity	6
Exposome mapping in chronic respiratory diseases: the added value of digital technology	6
Precision medicine to personalize medicine in allergic airway disease	6
Pathology of T-cell-mediated drug hypersensitivity reactions and impact of tolerance mechanisms on patient susceptibility	6
New causes of occupational allergic contact dermatitis	6
Poor statistical reporting: do we have a reason for concern? A narrative review and recommendations	6